These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32839593)

  • 41. An unequal activism for an unequal epidemic?
    Selemogo M
    Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Averting Future Vaccine Injustice.
    Moon S; Alonso Ruiz A; Vieira M
    N Engl J Med; 2021 Jul; 385(3):193-196. PubMed ID: 34265190
    [No Abstract]   [Full Text] [Related]  

  • 43. Global access to vaccines: Poor nations are being lured into a debt trap.
    Puliyel JM; Shrivastava A
    BMJ; 2008 May; 336(7651):974-5. PubMed ID: 18456599
    [No Abstract]   [Full Text] [Related]  

  • 44. Global health initiatives in cardiothoracic surgery: Ethical considerations and guidelines.
    Fenton KN; Novick WM; Entwistle JW; Moffatt-Bruce SD; Sade RM;
    J Thorac Cardiovasc Surg; 2021 Jun; 161(6):2114-2118. PubMed ID: 33077177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The medication cycle: its impact on access to and adequate use of drugs.
    Homedes N; Ugalde A
    Salud Colect; 2015 Mar; 11(1):5-8. PubMed ID: 25853826
    [No Abstract]   [Full Text] [Related]  

  • 46. Knowledge transfer for large-scale vaccine manufacturing.
    Price WN; Rai AK; Minssen T
    Science; 2020 Aug; 369(6506):912-914. PubMed ID: 32792464
    [No Abstract]   [Full Text] [Related]  

  • 47. Globalising strategies to meet global challenges: the case of ageing and dementia.
    Parra MA; Butler S; McGeown WJ; Brown Nicholls LA; Robertson DJ
    J Glob Health; 2019 Dec; 9(2):020310. PubMed ID: 31777656
    [No Abstract]   [Full Text] [Related]  

  • 48. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Phelan AL; Eccleston-Turner M; Rourke M; Maleche A; Wang C
    Lancet; 2020 Sep; 396(10254):800-802. PubMed ID: 32910908
    [No Abstract]   [Full Text] [Related]  

  • 49. An ethical framework for global vaccine allocation.
    Emanuel EJ; Persad G; Kern A; Buchanan A; Fabre C; Halliday D; Heath J; Herzog L; Leland RJ; Lemango ET; Luna F; McCoy MS; Norheim OF; Ottersen T; Schaefer GO; Tan KC; Wellman CH; Wolff J; Richardson HS
    Science; 2020 Sep; 369(6509):1309-1312. PubMed ID: 32883884
    [No Abstract]   [Full Text] [Related]  

  • 50. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 vaccines in development.
    Krammer F
    Nature; 2020 Oct; 586(7830):516-527. PubMed ID: 32967006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 vaccine: vaccinate the young to protect the old?
    Giubilini A; Savulescu J; Wilkinson D
    J Law Biosci; 2020; 7(1):lsaa050. PubMed ID: 32959006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Broockman D; Kalla J; Guerrero A; Budolfson M; Eyal N; Jewell NP; Magalhaes M; Sekhon JS
    Vaccine; 2021 Jan; 39(2):309-316. PubMed ID: 33334616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Wendler D; Ochoa J; Millum J; Grady C; Taylor HA
    Science; 2020 Dec; 370(6522):1277-1279. PubMed ID: 33273060
    [No Abstract]   [Full Text] [Related]  

  • 55. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Who gets a COVID vaccine first? Access plans are taking shape.
    Subbaraman N
    Nature; 2020 Sep; 585(7826):492-493. PubMed ID: 32948865
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-vaccine results are on the way - and scientists' concerns are growing.
    Mallapaty S; Ledford H
    Nature; 2020 Oct; 586(7827):16-17. PubMed ID: 32978611
    [No Abstract]   [Full Text] [Related]  

  • 58. Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues.
    Spinola SM; Zimet GD; Ott MA; Katz BP
    J Infect Dis; 2020 Oct; 222(9):1572-1574. PubMed ID: 32845303
    [No Abstract]   [Full Text] [Related]  

  • 59. Navigating inequities: a roadmap out of the pandemic.
    Ismail SJ; Tunis MC; Zhao L; Quach C
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33479019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    Schmidt H; Gostin LO; Williams MA
    JAMA; 2020 Nov; 324(20):2023-2024. PubMed ID: 33052391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.